Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 22


Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens.

Fernandes-Cerqueira C, Ossipova E, Gunasekera S, Hansson M, Mathsson L, Catrina AI, Sommarin Y, Klareskog L, Lundberg K, Rönnelid J, Göransson U, Jakobsson PJ.

Arthritis Res Ther. 2015 Jun 10;17:155. doi: 10.1186/s13075-015-0666-6.


Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis.

Turesson C, Mathsson L, Jacobsson LT, Sturfelt G, Rönnelid J.

Ann Rheum Dis. 2013 Dec;72(12):2047-8. doi: 10.1136/annrheumdis-2013-203510. Epub 2013 Jun 5. No abstract available.


Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.

Brink M, Hansson M, Mathsson L, Jakobsson PJ, Holmdahl R, Hallmans G, Stenlund H, Rönnelid J, Klareskog L, Rantapää-Dahlqvist S.

Arthritis Rheum. 2013 Apr;65(4):899-910. doi: 10.1002/art.37835.


Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides.

Hansson M, Mathsson L, Schlederer T, Israelsson L, Matsson P, Nogueira L, Jakobsson PJ, Lundberg K, Malmström V, Serre G, Holmdahl R, Nystrand M, Klareskog L, Rönnelid J.

Arthritis Res Ther. 2012 Oct 1;14(5):R201. doi: 10.1186/ar4039.


Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.

Ahlin E, Mathsson L, Eloranta ML, Jonsdottir T, Gunnarsson I, Rönnblom L, Rönnelid J.

Lupus. 2012 May;21(6):586-95. doi: 10.1177/0961203311434938. Epub 2012 Feb 2.


Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis.

Fisher BA, Plant D, Brode M, van Vollenhoven RF, Mathsson L, Symmons D, Lundberg K, Rönnelid J, Venables PJ.

Ann Rheum Dis. 2011 Jun;70(6):1095-8. doi: 10.1136/ard.2010.138909. Epub 2011 Mar 1.


Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis.

Raza K, Mathsson L, Buckley CD, Filer A, Rönnelid J.

Ann Rheum Dis. 2010 Mar;69(3):627-8. doi: 10.1136/ard.2009.118448. Epub 2009 Oct 20. No abstract available.


The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.

Wenink MH, Santegoets KC, Roelofs MF, Huijbens R, Koenen HJ, van Beek R, Joosten I, Meyer-Wentrup F, Mathsson L, Ronnelid J, Adema GJ, Bonvini E, Koenig S, van den Berg WB, van Riel PL, Radstake TR.

J Immunol. 2009 Oct 1;183(7):4509-20. doi: 10.4049/jimmunol.0900153. Epub 2009 Sep 4.


Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.

Eloranta ML, Lövgren T, Finke D, Mathsson L, Rönnelid J, Kastner B, Alm GV, Rönnblom L.

Arthritis Rheum. 2009 Aug;60(8):2418-27. doi: 10.1002/art.24686.


Immune complex-mediated cytokine production is regulated by classical complement activation both in vivo and in vitro.

Rönnelid J, Ahlin E, Nilsson B, Nilsson-Ekdahl K, Mathsson L.

Adv Exp Med Biol. 2008;632:187-201. Review.


Profound and paradoxical impact on arthritis and autoimmunity of the rat antigen-presenting lectin-like receptor complex.

Guo JP, Bäckdahl L, Marta M, Mathsson L, Rönnelid J, Lorentzen JC.

Arthritis Rheum. 2008 May;58(5):1343-53. doi: 10.1002/art.23434.


Inflammatory cytokines, behaviour and age as determinants of self-rated health in women.

Undén AL, Andréasson A, Elofsson S, Brismar K, Mathsson L, Rönnelid J, Lekander M.

Clin Sci (Lond). 2007 Jun;112(6):363-73.


Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis.

Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Rönnelid J.

Ann Rheum Dis. 2007 Jan;66(1):59-64. Epub 2006 Aug 10.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk